Fact CheckerSign in

NCT07097896Recruiting

Endobronchial Silicone Valve for Patients With Emphysema

Bronchoscopic Lung Volume Reduction With Endobronchial Silicone Valve for Patients With Emphysema: a Randomised Controlled Trial

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

The purpose of this research is to evaluate the efficacy and safety of endobronchial silicone valve in patients with severe emphysema.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
147 (estimated)
First submitted
30 Jul 2025
Start date
8 Jul 2025
Primary completion date
Jul 2027
Lead sponsor
China-Japan Friendship Hospital
Diseases
COPD
NCT number
NCT07097896

What you commit to

  • Study type: Interventional
  • Planned participants: 147
  • From 8 Jul 2025 to the primary completion date, Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Had a prior lung transplant, lung volume reduction surgery, bullectomy or lobectomy

Other illness

  • Had a heart attack or congestive heart failure within the last 6 months
  • Have heart arrhythmia

Other

  • Had two or more hospitalizations over the last year for a COPD exacerbation
  • Had two or more hospitalizations over the last year for pneumonia
  • Is alpha-1 antitrypsin deficient

Who the study is looking for

  • Clinical and radiological evidence of emphysema
  • Nonsmoking for 4 months prior to screening interview
  • BMI less than 35 kg/m2
  • Stable on current medication regimen
  • Forced expiratory volume in one second (FEV1) between 15% and 45% of predicted value
  • Residual Volume less than 175% predicted (determined by body plethysmography)
  • Little or no collateral ventilation (CV-) as determined using the Chartis System

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
China-Japan Friendship Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.